Victrex plc (LON:VCT) Plans Dividend of GBX 46.14

Victrex plc (LON:VCT) declared a dividend on Tuesday, December 3rd,Upcoming Dividends.Co.Uk reports. Investors of record on Thursday, January 23rd will be paid a dividend of GBX 46.14 ($0.58) per share on Friday, February 21st. This represents a yield of 5.26%. The ex-dividend date of this dividend is Thursday, January 23rd. This is a positive change from Victrex’s previous dividend of $13.42. The official announcement can be accessed at this link.

Victrex Price Performance

Shares of LON VCT opened at GBX 1,063.40 ($13.47) on Wednesday. The stock has a market capitalization of £925.47 million, a price-to-earnings ratio of 3,051.43, a PEG ratio of 1.92 and a beta of 0.69. Victrex has a 12 month low of GBX 816 ($10.34) and a 12 month high of GBX 1,575 ($19.96). The firm’s 50 day simple moving average is GBX 890.38 and its 200-day simple moving average is GBX 1,035.67. The company has a debt-to-equity ratio of 16.99, a current ratio of 5.30 and a quick ratio of 1.99.

Insider Transactions at Victrex

In other Victrex news, insider Brendan Connolly acquired 980 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was purchased at an average price of GBX 1,019 ($12.91) per share, for a total transaction of £9,986.20 ($12,653.57). Also, insider Jane Toogood acquired 508 shares of the company’s stock in a transaction that occurred on Tuesday, September 24th. The stock was acquired at an average price of GBX 937 ($11.87) per share, with a total value of £4,759.96 ($6,031.37). Over the last three months, insiders have acquired 3,591 shares of company stock valued at $3,474,569. Corporate insiders own 1.64% of the company’s stock.

Analyst Ratings Changes

Separately, Berenberg Bank decreased their price objective on shares of Victrex from GBX 1,491 ($18.89) to GBX 1,290 ($16.35) and set a “hold” rating on the stock in a report on Wednesday, August 28th.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.